Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Table of Contents

March 01, 1997; Volume 51,Issue 3

Erratum

  • You have access
    Errata
    Molecular Pharmacology March 1997, 51 (3) 1/a-1a;

Accelerated Communication

  • You have access
    Antagonist-Stimulated Internalization of the G Protein-Coupled Cholecystokinin Receptor
    B. F. Roettger, D. Ghanekar, R. Rao, C. Toledo, J. Yingling, D. Pinon and L. J. Miller
    Molecular Pharmacology March 1997, 51 (3) 357-362;

Articles

  • You have access
    Extent and Character of Phenobarbital-Mediated Changes in Gene Expression in the Liver
    Felix W. Frueh, Ulrich M. Zanger and Urs A. Meyer
    Molecular Pharmacology March 1997, 51 (3) 363-369;
  • You have access
    Genetic Polymorphism of Human CYP2E1: Characterization of Two Variant Alleles
    Yin Hu, Mikael Oscarson, Inger Johansson, Qun-Ying Yue, Marja-Liisa Dahl, Marco Tabone, Sarino Arincò, Emanuele Albano and Magnus Ingelman-Sundberg
    Molecular Pharmacology March 1997, 51 (3) 370-376;
  • You have access
    Functional Consequences of Reduced Retinoic Acid Receptor γ Expression in a Human Squamous Cell Carcinoma Line
    Ricardo I. Monzon, Catherine Fillmore and Laurie G. Hudson
    Molecular Pharmacology March 1997, 51 (3) 377-382;
  • You have access
    Selective Inhibition of A-Raf and C-Raf mRNA Expression by Antisense Oligodeoxynucleotides in Rat Vascular Smooth Muscle Cells: Role of A-Raf and C-Raf in Serum-Induced Proliferation
    Catherine L. Cioffi, Michelle Garay, Joseph F. Johnston, Kathy McGraw, Russell T. Boggs, David Hreniuk and Brett P. Monia
    Molecular Pharmacology March 1997, 51 (3) 383-389;
  • You have access
    Regulation of Acetylcholine Release by Presynaptic Nicotinic Receptors at Developing Neuromuscular Synapses
    Wen-Mei Fu and Jiunn-Jiun Liu
    Molecular Pharmacology March 1997, 51 (3) 390-398;
  • You have access
    Reversal of Multidrug Resistance-Associated Protein-Mediated Drug Resistance by the Pyridine Analog PAK-104P
    Tomoyuki Sumizawa, Zhe-Sheng Chen, Yutaka Chuman, Kiyotomo Seto, Tatsuhiko Furukawa, Misako Haraguchi, Ayako Tani, Norimasa Shudo and Shin-Ichi Akiyama
    Molecular Pharmacology March 1997, 51 (3) 399-405;
  • You have access
    Arginine 52 and Histidine 54 Located in a Conserved Amino-Terminal Hydrophobic Region (LX2-R52-G-H54-X3-V-L) Are Important Amino Acids for the Functional and Structural Integrity of the Human Liver UDP-Glucuronosyltransferase UGT1*6
    Claire Senay, Mohamed Ouzzine, Eric Battaglia, Dorothy Pless, Virginie Cano, Brian Burchell, Anna Radominska, Jacques Magdalou and Sylvie Fournel-Gigleux
    Molecular Pharmacology March 1997, 51 (3) 406-413;
  • You have access
    6-Mercaptopurine Decreases the Bcl-2/Bax Ratio and Induces Apoptosis in Activated Splenic B Lymphocytes
    Sonsoles Hortelano and Lisardo Boscá
    Molecular Pharmacology March 1997, 51 (3) 414-421;
  • You have access
    Involvement of Activator Protein-1 and Nuclear Factor-κB Transcription Factors in the Control of the DT-Diaphorase Expression Induced by Mitomycin C Treatment
    Kang-Shen Yao, Alexandre Hageboutros, Patricia Ford and Peter J. O’Dwyer
    Molecular Pharmacology March 1997, 51 (3) 422-430;
  • You have access
    Intracellular Routing and Inhibitory Activity of Oligonucleopeptides Containing a KDEL Motif
    Chantal Pichon, Khalil Arar, Alistair J. Stewart, Madeleine Duc Dodon, Louis Gazzolo, Pierre J. Courtoy, Roger Mayer, Michel Monsigny and Annie-Claude Roche
    Molecular Pharmacology March 1997, 51 (3) 431-438;
  • You have access
    Bryostatin 1 and Phorbol Ester Down-Modulate Protein Kinase C-α and -ε via the Ubiquitin/Proteasome Pathway in Human Fibroblasts
    Hyeon-Woo Lee, Lucinda Smith, George R. Pettit and Jeffrey Bingham Smith
    Molecular Pharmacology March 1997, 51 (3) 439-447;
  • You have access
    Copper-Dependent Oxidative and Topoisomerase II-Mediated DNA Cleavage by a Netropsin/4′-(9-acridinylamino)methanesulfon-m-anisidide Combilexin
    Jean-Pierre Henichart, Michael J. Waring, Jean-Francois Riou, William A. Denny and Christian Bailly
    Molecular Pharmacology March 1997, 51 (3) 448-461;
  • You have access
    Different Protein Kinase C Isozymes Mediate Lower Esophageal Sphincter Tone and Phasic Contraction of Esophageal Circular Smooth Muscle
    Uy Dong Sohn, Driss Zoukhri, Darlene Dartt, Christian Sergheraert, Karen M. Harnett, Jose Behar and Piero Biancani
    Molecular Pharmacology March 1997, 51 (3) 462-470;
  • You have access
    A Specific Inhibitory Action of Lithium on the 5-HT2cReceptor Expressed in Xenopus laevis Oocytes
    Toshiyuki Matsuoka, Tomoyuki Nishizaki and Kimiaki Sumino
    Molecular Pharmacology March 1997, 51 (3) 471-474;
  • You have access
    Voltage-Dependent Inhibition of RCK1 K+ Channels by Phenol, p-Cresol, and Benzyl Alcohol
    A. A. Elliott and J. R. Elliott
    Molecular Pharmacology March 1997, 51 (3) 475-483;
  • You have access
    Differential Subunit Dependence of the Actions of the General Anesthetics Alphaxalone and Etomidate at γ-Aminobutyric Acid Type A Receptors Expressed in Xenopus laevis Oocytes
    Enrico Sanna, Antonella Murgia, Anna Casula and Giovanni Biggio
    Molecular Pharmacology March 1997, 51 (3) 484-490;
  • You have access
    Heteropodatoxins: Peptides Isolated from Spider Venom that Block Kv4.2 Potassium Channels
    Michael C. Sanguinetti, Janice H. Johnson, Lance G. Hammerland, Paul R. Kelbaugh, Robert A. Volkmann, Nicholas A. Saccomano and Alan L. Mueller
    Molecular Pharmacology March 1997, 51 (3) 491-498;
  • You have access
    Modulation of α7 Nicotinic Receptor-Mediated Calcium Influx by Nicotinic Agonists
    M. Quik, J. Philie and J. Choremis
    Molecular Pharmacology March 1997, 51 (3) 499-506;
  • You have access
    Oxidation of Cysteine S-Conjugates by Rabbit Liver Microsomes and cDNA-Expressed Flavin-Containing Mono-oxygenases: Studies withS-(1,2-Dichlorovinyl)-l-cysteine,S-(1,2,2-Trichlorovinyl)-l-cysteine,S-Allyl-l-cysteine, andS-Benzyl-l-cysteine
    Sharon L. Ripp, Lila H. Overby, Richard M. Philpot and Adnan A. Elfarra
    Molecular Pharmacology March 1997, 51 (3) 507-515;
  • You have access
    Polarization of Adenosine Effects on Intracellular pH in A6 Renal Epithelial Cells
    V. Casavola, L. Guerra, S. J. Reshkin, K. A. Jacobson and H. Murer
    Molecular Pharmacology March 1997, 51 (3) 516-523;
  • You have access
    Radiolabeling of the Rat P2X4 Purinoceptor: Evidence for Allosteric Interactions of Purinoceptor Antagonists and Monovalent Cations with P2X Purinoceptors
    Anton D. Michel, Kerry J. Miller, Kenneth Lundström, Gary N. Buell and Patrick P.A. Humphrey
    Molecular Pharmacology March 1997, 51 (3) 524-532;
Back to top
PreviousNext

In this issue

Molecular Pharmacology
Vol. 51, Issue 3
1 Mar 1997
  • Table of Contents
  • About the Cover
  • Index by author
Sign up for alerts

Jump to

  • Erratum
  • Accelerated Communication
  • Articles
  • Most Cited
  • Most Read
Loading
  • SB-431542 Is a Potent and Specific Inhibitor of Transforming Growth Factor-β Superfamily Type I Activin Receptor-Like Kinase (ALK) Receptors ALK4, ALK5, and ALK7
  • The G-Protein-Coupled Receptors in the Human Genome Form Five Main Families. Phylogenetic Analysis, Paralogon Groups, and Fingerprints
  • Pharmacological Properties of Y-27632, a Specific Inhibitor of Rho-Associated Kinases
  • Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines.
  • The Orphan Human Pregnane X Receptor Mediates the Transcriptional Activation of CYP3A4 by Rifampicin through a Distal Enhancer Module
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics